UroGen Pharma Ltd - URGN Future Profit

URGN (UroGen Pharma Ltd) - company brandmark

UroGen Pharma Ltd. (URGN) ensures uninterrupted access to therapy thanks to streamlined oncology drug supply chains. The company's earnings forecast history reflects market expectation trends, with the indicator settling at 0.12. The issuer is implementing a local chemotherapy platform to minimize surgical interventions, while the unique RTGel guarantees pricing power due to inelastic demand for non-surgical tumor treatment.

URGN: urogen.com Future Profit 03/03/2026 - 11/18/2026

UroGen - analytical breakdowns and key metrics (URGN)

- price and consensus price forecast:
Fundamental company analysis:urogen.com
Core merchandise of UroGen Pharma Ltd

This metric aggregates market expectations for net income, measuring the business's ability to generate cash flow after all operating and tax expenses. The analytical earnings forecast reflects the commercialization pace of the innovative gel from UroGen Pharma (URGN), where the upward trend confirms the effective monetization of patent protection and the drug's transition into an industry standard for urology.

Main competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|BCAX - Future Profit|PSNL: Future Profit|ERAS - Projected Future Earnings|Delcath (DCTH) - Expected Profit|YmAbs - Expected Net Income|AURA (Aura Biosciences Inc) - Projected Future Earnings|Expected Net Profit Candel Therapeutics CADL|Projected Future Earnings ARAY|SLS - Expected Net Profit|Projected Future Earnings ACTU (Actuate Therapeutics Inc)|Company Profit Forecast Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Projected Future Earnings|Expected Net Profit Protara Therapeutics, Inc.|FATE: Projected Future Earnings|WHWK - Company Profit Forecast|Expected Profit TScan Therapeutics, Inc.|Champions Oncology - Forward Earnings|Projected Future Earnings XBIT|Company Profit Forecast CEL-SCI Corp|Expected Profit OS Therapies OSTX|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit